Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Five-year results from a phase 2 study of oral fingolimod in relapsing multiple sclerosis.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
[Review on domestic published papers regarding the acute disseminated encephalomyelitis and its relations with rabies vaccination].
Scan-stratified case-control sampling for modeling blood-brain barrier integrity in multiple sclerosis.
Treatment with interferon-beta does not induce anti-nuclear and anti-neuronal serum autoantibodies in multiple sclerosis patients.
SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.
Postural orthostatic tachycardia syndrome: additional phenotypic feature of neuromyelitis optica spectrum disorder.
Treatment of Acute Relapses in Multiple Sclerosis.
Treatment of chronic inflammatory polyneuropathy may improve associated hearing loss: A case report and a review of the literature.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase signaling pathway: Diverse roles in modulating immune cell functions.
Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
A Combined Inspiratory and Expiratory Muscle Training Program Improves Respiratory Muscle Strength and Fatigue in Multiple Sclerosis.
Does Slowed Processing Speed Account for Executive Deficits in Multiple Sclerosis? Evidence From Neuropsychological Performance and Structural Neuroimaging.
Aurintricarboxylic Acid Ameliorates Experimental Autoimmune Encephalomyelitis by Blocking Chemokine-Mediated Pathogenic Cell Migration and Infiltration.
Cerebral venous thrombosis after lumbar puncture and intravenous high dose corticosteroids: A case report of a childhood multiple sclerosis.
BREMSO: a simple score to predict early the natural course of multiple sclerosis.
Interleukin-10 expression during the acute phase is a putative prerequisite for delayed viral elimination in a murine model for multiple sclerosis.
The role of IFNβ in the treatment of MSand EAE - In the perspective of inflammasomes.
Assessment and rehabilitation of driver skills: subjective experiences of people with multiple sclerosis and health professionals.
Astrocyte loss and astrogliosis in neuroinflammatory disorders.
Grey matter lesions in MS: From histology to clinical implications.
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy.
Vitamin B(12) in neurology and ageing; Clinical and genetic aspects.
Influence of melatonin supplementation on serum antioxidative properties and impact of the quality of life in multiple sclerosis patients.
What is microglia neurotoxicity (Not)?

Pages